Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mariana Koczywas"'
Autor:
Finly Zachariah, Lucia Kinsey, Mariana Koczywas, Denise Morse, Matthew Loscalzo, William Dale
Publikováno v:
Journal of Pain and Symptom Management. 57:448
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9120e5540d1e1ed71303529efb308862
https://doi.org/10.1016/j.jpainsymman.2018.12.194
https://doi.org/10.1016/j.jpainsymman.2018.12.194
Autor:
Suresh S. Ramalingam, P. C. Mack, Barbara J. Gitlitz, Frances A. Shepherd, Mariana Koczywas, Jeff Longmate, Derick H Lau, Athanassios Argiris, David R. Gandara, Natasha B. Leighl, Karen L. Reckamp, Primo N. Lara, Chandra P. Belani, John J. Wright
Publikováno v:
Clinical Lung Cancer. 12:33-37
Background The proteasome inhibitor bortezomib sensitizes tumor cells to chemotherapy-induced apoptosis. In preclinical non–small-cell lung cancer (NSCLC) models, p53-dependent growth arrest after bortezomib treatment resulted in reduced cytotoxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680684e347cba63b7a5c650eecd910b7
https://doi.org/10.3816/clc.2011.n.004
https://doi.org/10.3816/clc.2011.n.004
Autor:
Primo N, Lara, Mariana, Koczywas, David I, Quinn, Heinz Josef, Lenz, Angela M, Davies, Derick H M, Lau, Paul H, Gumerlock, Jeff, Longmate, James H, Doroshow, David, Schenkein, Oscar, Kashala, David R, Gandara
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 1(2)
This phase I study was performed to determine the dose-limiting toxicity and maximum tolerated dose (MTD) of docetaxel in combination with bortezomib in patients with advanced non-small cell lung cancer (NSCLC) or other solid tumors.Patients were enr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7eb873482f1f109d9d67f73bce92eae6
https://pubmed.ncbi.nlm.nih.gov/17409841
https://pubmed.ncbi.nlm.nih.gov/17409841
Autor:
Roderich E. Schwarz, George Somlo, Timothy W. Synold, Bixin Xi, Yun Yen, Paul Frankel, Robert J. Morgan, James H. Doroshow, Warren Chow, Mariana Koczywas, Benjamin Paz, David Chu, Kim Margolin, Susan Stalter, Przemyslaw Twardowski, Lawrence D. Wagman, Lucille Leong, Merry Tetef, Stephen Shibata, Dean Lim, Paul Lin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(4)
Purpose: To determine the maximally tolerated dose, toxicity, and pharmacokinetics of i.p. gemcitabine. Experimental Design: Patients had peritoneal carcinomatosis. Gemcitabine (40, 80, 120, or 160 mg/m2) was administered into the peritoneal cavity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd8f6f5b3629b7758d15dee4eddb842
https://pubmed.ncbi.nlm.nih.gov/17317834
https://pubmed.ncbi.nlm.nih.gov/17317834
Publikováno v:
The Journal of Supportive Oncology. 8:A9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c514c9b709ede67f298607af847fad6
https://doi.org/10.1016/j.suponc.2010.09.016
https://doi.org/10.1016/j.suponc.2010.09.016
Autor:
Derick H Lau, David P. Schenkein, Jeff Longmate, Mariana Koczywas, Angela M. Davies, Paul H. Gumerlock, James H. Doroshow, David I. Quinn, Oscar Kashala, Primo N. Lara, Heinz-Josef Lenz, David R. Gandara
Publikováno v:
Journal of Thoracic Oncology. (2):126-134
Background: This phase I study was performed to determine the dose-limiting toxicity and maximum tolerated dose (MTD) of docetaxel in combination with bortezomib in patients with advanced non-small cell lung cancer (NSCLC) or other solid tumors. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141dc7ddb38ee041ee70a19e558d0998